Scientific Sessions 2024  /  Research and Innovation Through the Pipeline  /  Innovation and Product Development in Cardiac Therapeutics
Logo

American Heart Association

  106
  0

Final ID:

Innovation and Product Development in Cardiac Therapeutics

  • Pina, Ileana  ( Thomas Jefferson University , Cleveland Heights , Ohio , United States )
  • Srivastava, Deepak  ( GLADSTONE INSTITUTES , San Francisco , California , United States )
  • Haldar, Saptarsi  ( Brigham and Women's Hospital , Boston , Massachusetts , United States )
  • Van, Eva  ( HUBRECHT INSTITUTE , Utrecht , Netherlands )
    • Author Disclosures:
    Ileana Pina: DO have relevant financial relationships ; Advisor:Boehringer Ingelheim:Active (exists now) ; Employee:Thomas Jefferson University:Active (exists now) ; Advisor:Bayer:Past (completed) | Deepak Srivastava: DO have relevant financial relationships ; Other (please indicate in the box next to the company name):Tenaya Therapeutics - co-founder, board member, stockholder, scientific advisory board member:Active (exists now) | Saptarsi Haldar: No Answer | Eva Van: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Research and Innovation Through the Pipeline

Friday, 11/15/2024 , 02:00PM - 03:00PM

Early Career

More abstracts on this topic:
Physician Innovator: from Concept to Commercialization

Silva Jennifer, Patton Kristin

Innovation through Informatics: Multimedia and Global Impact

Espinoza Juan

More abstracts from these authors:
Distinguished Scientist Lecture

Srivastava Deepak

Base Editing to Treat Arrhythmogenic Cardiomyopathy

De Windt Leon, Van Eva

You have to be authorized to contact abstract author. Please, Login
Not Available